Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) – Stock analysts at William Blair raised their Q4 2022 earnings per share (EPS) estimates for Henry Schein in a research report issued to clients and investors on Tuesday, August 2nd. William Blair analyst J. Kreger now expects that the company will post earnings per share of $1.22 for the quarter, up from their previous forecast of $1.17. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.85 per share.
Henry Schein (NASDAQ:HSIC – Get Rating) last posted its earnings results on Tuesday, August 2nd. The company reported $1.16 EPS for the quarter, hitting the consensus estimate of $1.16. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. The firm had revenue of $3.03 billion for the quarter, compared to analyst estimates of $3.12 billion. During the same period last year, the company earned $1.11 earnings per share. Henry Schein’s revenue for the quarter was up 2.1% compared to the same quarter last year.
Henry Schein Stock Up 1.7 %
Shares of HSIC opened at $75.38 on Friday. The company has a current ratio of 1.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.18. Henry Schein has a 12 month low of $70.25 and a 12 month high of $92.68. The stock’s 50 day moving average is $77.98 and its two-hundred day moving average is $81.97. The firm has a market cap of $10.41 billion, a P/E ratio of 16.18, a PEG ratio of 2.01 and a beta of 0.75.
Insider Buying and Selling
In related news, EVP Gerald A. Benjamin sold 11,489 shares of Henry Schein stock in a transaction that occurred on Thursday, May 26th. The stock was sold at an average price of $85.47, for a total transaction of $981,964.83. Following the transaction, the executive vice president now owns 95,616 shares in the company, valued at $8,172,299.52. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 1.00% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Henry Schein
A number of institutional investors have recently added to or reduced their stakes in HSIC. Covestor Ltd purchased a new position in Henry Schein during the fourth quarter worth approximately $35,000. National Bank of Canada FI purchased a new stake in Henry Schein in the fourth quarter valued at $42,000. Venture Visionary Partners LLC purchased a new stake in Henry Schein in the second quarter valued at $46,000. Quent Capital LLC purchased a new stake in Henry Schein in the fourth quarter valued at $47,000. Finally, Dupont Capital Management Corp raised its position in Henry Schein by 46.2% in the first quarter. Dupont Capital Management Corp now owns 611 shares of the company’s stock valued at $53,000 after purchasing an additional 193 shares during the period. Hedge funds and other institutional investors own 94.30% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Get a free copy of the StockNews.com research report on Henry Schein (HSIC)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.